Pharma-Bio Serv (OTCMKTS:PBSV) Announces Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSV) announced its quarterly earnings results on Monday. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.35, reports. The business had revenue of $2.47 million during the quarter, compared to analyst estimates of $2.70 million. Pharma-Bio Serv had a negative net margin of 8.18% and a negative return on equity of 5.61%.

Pharma-Bio Serv Stock Performance

Shares of OTCMKTS:PBSV opened at $0.43 on Wednesday. The company has a market capitalization of $9.86 million, a P/E ratio of -14.33 and a beta of 0.53. Pharma-Bio Serv has a fifty-two week low of $0.31 and a fifty-two week high of $0.90. The company’s 50-day moving average is $0.55 and its 200 day moving average is $0.57.

Pharma-Bio Serv Announces Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, March 20th. Shareholders of record on Friday, February 28th will be issued a dividend of $0.075 per share. The ex-dividend date of this dividend is Friday, February 28th. Pharma-Bio Serv’s dividend payout ratio is -250.00%.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.